Matthew Weiss
Patterson Belknap Webb & Tyler LLP
Articles
Federal Circuit Upholds Jury Award, Weighs in on Willfulness Standard, in Adynovate® Dispute
USA - March 30 2021 According to the Federal Circuit, $173 million was the right damages award for almost three years of patent infringement resulting from Baxalta’s…
Sandoz Petitions the Supreme Court for Review of Enbrel® Patent License
USA - March 8 2021 The fight over proposed Enbrel® (etanercept) biosimilar Erelzi® continues. Sandoz Inc., Sandoz International GmbH and Sandoz GmbH (“Sandoz”) recently…
Magistrate Judge Reyes Recommends Dismissal of DJ Action Against Assignee That Never Owned The Patent-In-Suit
USA - March 2 2021 On February 9, 2021, United States Magistrate Judge Ramon E. Reyes, Jr. (E.D.N.Y.) recommended that Sell Below Cost USA LLC’s (“Sell Below”) DJ…
Federal Circuit Axes Amgen Antibody Patents, Finding Lack of Enablement
USA - February 18 2021 The Federal Circuit considered its 35 U.S.C. § 112 enablement case law and found that “the enablement inquiry for claims that include functional…
FDA Approves Breyanzi®—A New Biologic for Treating Large B-Cell Lymphoma
USA - February 9 2021 On February 5, 2021, the FDA approved Juno Therapeutics, Inc.’s Breyanzi® (lisocabtagene maraleucel) for “treatment of adult patients with relapsed…
